Clinical Presentation and Management of Coronavirus Disease 2019 in Renal Allograft Recipients: A Case Series
Abhijith C1, Archin Ann Jacob1, Sukanya Yesodhar1, Sulfath TS2★★ Corresponding author
- 1Department of Pharmacy Practice, S.C.S College of Pharmacy, Harapanahalli, Karnataka, INDIA.
- 2Clinical Pharmacist, IQRAA International Hospital and Research Centre, Calicut, Kerala, INDIA.
CORRESPONDENCE
Sulfath TS
Clinical Pharmacist, IQRAA International Hospital and Research Centre, Calicut, Kerala, INDIA.
Received: 07-05-2021; Revised: 03-06-2021; Accepted: 25-06-2021.
Volume 13, Issue 3 · pp. 309–311 · PUBLISHED · DOI: 10.5530/jyp.2021.13.62
ABSTRACT
Complications of coronavirus disease 2019 infection in renal transplant recipients are associated with significant morbidity and mortality and the existence of co-morbidities are more likely to develop serious illness. In this case series the clinical outcomes of coronavirus disease 2019 in 6 recipients tested positive is explained. D-dimer, ferritin and C-reactive protein values are elevated in all cases. The patients were on immunosuppressant therapy and had stable graft function before coronavirus disease 2019 infection. After the diagnosis, management included reduction and withdrawal of immunosuppression and significant changes in corticosteroids. One of our patients showed significant improvement without dosage adjustment of immunosuppressant
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
C, A., Jacob, A. A., Yesodhar, S., & TS, S. (). Clinical Presentation and Management of Coronavirus Disease 2019 in Renal Allograft Recipients: A Case Series. Journal of Young Pharmacists, 13(3), 309–311. https://doi.org/10.5530/jyp.2021.13.62